Prodystonic effects of riluzole in an animal model of idiopathic dystonia related to decreased total power in the red nucleus? (Q73672902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Prodystonic effects of riluzole in an animal model of idiopathic dystonia related to decreased total power in the red nucleus? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A Richter

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Gernert

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W Löscher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

133-141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

Anaesthetic properties of phencyclidine (PCP) and analogues may be related to their interaction with Na+ channels.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Primate models of movement disorders of basal ganglia origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

The electrical activity is impaired in the red nucleus of dt(sz) mutant hamsters with paroxysmal dystonia: an EEG power spectrum analysis of depth electrode recordings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Physiology of basal ganglia disorders: an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Involuntary movement disorders associated with felbamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

The glycine/NMDA receptor ligand (+)-HA-966 but not D-cycloserine has potent antidystonic efficacy in a genetic animal model of dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Gonadal sex hormones and dystonia: experimental studies in genetically dystonic hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Alterations in the brain GABAA/benzodiazepine receptor-chloride ionophore complex in a genetic model of paroxysmal dystonia: a quantitative autoradiographic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Electrophysiological actions of felbamate on rat striatal neurones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a mutant hamster model of paroxysmal dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Effects of riluzole (2-amino-6-trifluoromethoxy benzothiazole) on striatal neurochemical markers in the rat, with special reference to the dopamine, choline, GABA and glutamate synaptosomal high affinity uptake systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Neuropathological studies in a mutant hamster model of paroxysmal dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Lamotrigine-antiparkinsonian activity by blockade of glutamate release?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

Lamotrigine in Parkinson's disease — a double blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901075-3

10.1016/S0014-2999(97)01075-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286614%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference